(Exact name of Registrant as specified in its charter)

 

---

 

Delaware		000-22390		74-2657168
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

9220 Kirby Drive, Suite 500

Houston, Texas 77054

(Address of principal executive offices, including zip code)

 

(713) 432-0300

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

¨	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

---

 

 

---

 

---

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The employment of Mark L. Iske, Senior Vice President of Operations was terminated on Monday, August 20, 2007. Mr. Iske was an officer of the Company.

 

On Friday, August 24, 2007 the Company appointed Michael “Chad” Adair as its Director of Operations (non-officer position). Mr. Adair has twenty years of operations, manufacturing and engineering experience including nine years with Delphi Medical Systems.

 

 

Item 9.01

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

		None